Overview

Treatment of Recently Acquired Hepatitis C Virus Infection

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
To determine whether response guided treatment with pegylated interferon +/- ribavirin is effective for the treatment of recently acquired hepatitis C infection. Response guided treatment is when the length of treatment is determined by how quickly you respond to the treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Kirby Institute
Treatments:
Peginterferon alfa-2a
Ribavirin